The other four recipients are the hospitals that will be involved in the clinical trial, being the Royal Prince Alfred Hospital, Strathfield Private Hospital, Royal North Shore Hospital and Concord Repatriation General Hospital. The recipients will receive a prize to go towards furthering their research on microRNA replacement therapy for the treatment of malignant pleural mesothelioma and non-small cell lung cancer .
